BRD2 and non-Hodgkin lymphoma: After 3 months of chemotherapy, FSH increased to 0.12 SDS (-0.50 to 1.13) in patients with SR/IR-ALL and to 0.32 SDS (-0.69 to 3.10) in boys with NHL (Figure 4C).